Charles River Laboratories to Participate in Upcoming Investor Conferences

Nov. 16, 2021 13:00 UTC



WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at two upcoming investor conferences, including:

  • Jefferies London Healthcare Conference on Thursday, November 18th, with a pre-recording of the presentation available starting at 8:00 a.m. GMT (3:00 a.m. ET); and
  • Evercore ISI 4th Annual HealthCONx Conference on Wednesday, December 1st, at 9:40 a.m. ET.

Management will present an overview of Charles River’s strategic focus and business developments.

A webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at A webcast replay will be accessible through the same website after each event and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit


Investor Relations Contact:
Todd Spencer
Corporate Vice President, Investor Relations


Source: Charles River Laboratories International, Inc.

Back to news